It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...

The doctor recommended getting updated flu vaccines annually to lower the risk of contracting the virus and be protected from ...

A free trade agreement (FTA) with the EU is a top priority for the Thai government, while businesses on both sides support a ...

Newness is a difficult creature to tame. But advertising and marketing depend on their ability to do just that, to take on ...

GSK’s NgG shot is based on generalised modules ... Germany, Spain, Brazil, the Philippines, and South Africa, with a readout expected in 2025. Meanwhile, some research has found that vaccines ...

EU mid-market update: Trump adds Middle East tensions to macro picture as trade war keeps volatility high; Novo Nordisk rises ...

The lawsuit claims GlaxoSmithKline replaced Flovent with an identical generic version, hurting patients whose insurance wouldn't cover it and costing taxpayers money. Arizona Attorney General Kris ...

CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

It came as the boss of the London-listed firm cheered an ‘excellent’ performance in 2024. GSK has increased its long-term sales guidance amid hopes for a boost from new speciality medicines ...

Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run. Is there scope for more growth? The content of this article is ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...